Related Experiment Video
Updated: Dec 9, 2025

28:15
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
12.6K
Molecular Pathogenesis and Classification of Colorectal Carcinoma.
Anup Kasi1, Shivani Handa2, Sajjad Bhatti1
1Department of Medicine, Division of Medical Oncology, Kansas University Medical Center, Kansas City, KS, U.S.A.
Current Colorectal Cancer Reports
|September 9, 2020
Summary
Understanding colorectal cancer pathogenesis is enhanced by reviewing genomic research. Key findings include a unified molecular classification system aiding in predicting treatment response.
Area of Science:
- Genomic research
- Molecular biology
- Cancer pathogenesis
Background:
- Colorectal cancer (CRC) develops through complex genetic and epigenetic changes.
- Understanding these molecular pathways is crucial for effective treatment.
Purpose of the Study:
- To review historical and recent genomic research on colorectal cancer.
- To enhance the understanding of colorectal cancer pathogenesis.
- To present key molecular pathways, genetic mutations, and tumor sidedness differences.
Main Methods:
- Literature review of genomic research in colorectal carcinogenesis.
- Analysis of molecular classification systems for colorectal cancer.
- Synthesis of current knowledge on molecular pathogenesis.
Main Results:
- The 2015 consensus molecular subtypes (CMS) unified CRC classification into four groups.
- CMS classification improves understanding of molecular and immune signatures.
- This classification impacts predictions of clinical behavior and therapeutic response.
Conclusions:
- Current literature and expert experience highlight important molecular pathogenesis pathways.
- Key genetic mutations and differences in left vs. right-sided tumors are discussed.
- The molecular classification of colorectal cancers provides a framework for personalized medicine.
Related Concept Videos
Tumor Progression
7.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K
Mutagenicity and Carcinogenicity
1.7K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.7K
Metastasis
6.2K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.2K
Cancers Originate from Somatic Mutations in a Single Cell
14.3K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.3K
Cancer
53.1K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.1K
Cancer-Critical Genes I: Proto-oncogenes
10.8K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.8K

